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Abstract
Background: Given the increasing number of lead poisoning in opioids users and since no study has been conducted
so far to review lead poisoning in methamphetamine (crystal) users, this study aimed to investigate blood lead level in
methamphetamine addicts.
Methods: This study was conducted on 20 patients with methamphetamine poisoning and their blood lead level was
measured. The subjects were selected from among patients with a history of continuous use of methamphetamine,
without a history of using opiates in the past 6 months confirmed by a negative urine tests, and without a history of
heavy metal poisoning.
Results: Of all, 18 patients were male and the mean age was 32 ± 10 years; 17 patients were abusing the drug
via inhalation and three persons via oral administration. The mean blood lead level was 2.3 ± 1.1 μg/dL and
poisoning was not observed in any of the cases. Blood lead level was not associated with age, sex, dosage, and
route of administration.
Conclusion: Although blood lead level was not at poisoning level in people who only used methamphetamine in
Iran, due to the simultaneous use of other substances and because of non-specific symptoms, lead poisoning must be
suspected in all cases of substances poisoning.
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Background
Lead is a heavy metal that is abundant in the environ-
ment and can cause acute and chronic poisoning. Items
such as exhaust gas from cars, contaminated food,
industrial waste water, and soil are the main sources of
this type of pollution. Inhalation, oral, or dermal exposure
to the mentioned sources of pollution can cause lead
poisoning [1, 2]. Lead poisoning can cause non-specific
protests such as abdominal pain, constipation, irritability,
myalgia, anorexia, difficulty concentrating, decreased
libido, headache etc. In addition, lead can cause irre-
versible neurological damage, kidney diseases, coronary
artery diseases, and reproductive disorders. Nonspecific
abdominal pain in this group of patients might be mis-
taken for acute abdomen, cholecystitis, and pancreatitis
and may result in unnecessary abdominal examinations
and even surgery [3].
Nowadays, due to increased level of safety in the work-
place, the incidence of industrial lead poisoning has de-
creased greatly. However new forms of this type of
poisoning has emerged. Since many years ago there have
been a number of reports on lead poisoning caused by the
use of substances such as opioids [4–7]. The existing
evidence suggests an increasing number of substances
abuse, especially opioids, in countries like Iran [8]; more-
over, some studies in the Middle East, Iran, and other
countries have reported the higher blood lead levels in
substance users. On the other hand, an increasing number
of studies have been conducted on opioids-related lead
contamination and poisoning [3, 9–16]. According to a
number of studies, some non-specific symptoms such as
abdominal pain, neuropathy, and anemia in patients
addicted to opioids have been improved via utilizing
specific treatments for lead poisoning [9, 17–19]. There-
fore, lead pollution in substances such as opioids is a new
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source of poisoning which is mainly due to adding lead or
its combinations to illegal substances during the prepar-
ation process. However, existence of lead in the abused
materials is a neglected fact that is sometimes even over-
looked in scientific studies. For example, Kamangar et al
suggest a link between opium use and cancer risk in their
review article [20]. But according to the contamination of
opium with lead which is confirmed in various studies
in different countries, and especially Iran [13, 15],
Mahmoodpoor et al said that this contamination could
be a contributing factor for the high prevalence of
cancer in opium users [21].
In addition to opioids and heroin [22, 23], there have
been some reports on lead contamination and toxicity in
other drugs, among which we may note marijuana [24]
and methamphetamine [23, 25]. Nowadays, there is an
increase in the number of amphetamine compounds in
Iran. In Iran, crystal or Shisheh is a general name which is
commonly used for some of these compounds [26, 27].
Recently, the transition from the traditional patterns of
using opioids to methamphetamine use has changed in to
a new health concern in Iran [28]. The increasing fre-
quency of crystal is due to its illegal manufacturing, thus
like other drugs, it is expected to observe cases of lead
poisoning among people who use this type of drug. Al-
though three studies were done on lead poisoning in the
methamphetamine users [23, 25, 29], their date backed to
more than 10 years ago and they were done on injecting
methamphetamine, so this study was carried out to evalu-
ate the blood lead level in inhalational and orally metham-
phetamine users.
Methods
This cross-sectional study was conducted on patients with
crystal (methamphetamine) poisoning who referred to
Loghman Hakim poisoning center Tehran Iran, in 2014.
Inclusion criteria were the followings: a history of
continuous use of methamphetamine for more than
6 months, urine test positive for methamphetamine,
not taking other opioids compounds (morphine deriva-
tives) in the past 6 months, negative qualitative test of
urine for drug compounds (morphine derivatives), and
no history of heavy metal poisoning as confirmed by
patients history. Everyday about ten patients with a
history of methamphetamine use refer to emergency
ward of Loghman hospital. However, in most cases, the
duration of continuous use of methamphetamine is less
than 6 months; in addition, most of the substance users
simultaneously use other opioids compounds as well.
Therefore, taking into consideration the inclusion cri-
teria, during the 6 months of the study only 20 patients
were diagnosed with sole methamphetamine poisoning
and after obtaining informed consent from patients or
their relatives, they were enrolled into the study. The
study received an ethical approval from the Ethics
Committee of Shahid Beheshti University of Medical
Sciences.
A checklist was used to record patients’ demographic
data including gender and age, the characteristics of
methamphetamine use (duration of use, dosage, and
route of administration), vital signs, and signs and symp-
toms at the time of the first visit. Then in accordance
with the relevant guidelines, 5 ml blood sample was
taken from each patient and sent to a laboratory to de-
termine patients’ blood lead levels. Samples were tested
via Atomic Abs method [30]. All the patients received
supportive treatments and if tests were indicative of lead
poisoning (greater than 25 μg/dL) the patients received
specific treatments. Finally, patients’ outcomes were
recorded.
SPSS for Windows version 22 was used for data analysis.
Qualitative variables were described using frequency and
percentage and quantitative variables were presented using
mean and standard deviation. Moreover, independent t test
was used to compare blood lead levels between sexes, age
groups, and different consumption rates.
Results
Of the 20 subjects, 18 patients (90%) were male and two
patients (10%) were female. Patients’ age ranged from 20
to 54 years and their mean age (SD) was 32 ± 10 years.
Of all, 17 patients (85%) were abusing the methampheta-
mine via inhalation and three persons (15%) were taking
it orally. The range and mean (SD) dosage of metham-
phetamine used by patients, respectively, were 0.5–2 gr/
day and 1 ± 0.5 gr/day in inhalation group and 1–10 gr/
day and 4.7 ± 4.7 gr/day in oral administration group.
The range and mean (SD) duration of methamphetamine
abuse were 1–5 years and 2.7 ± 1.5 years, respectively.
Table 1 presents the data on patients’ vital signs on admis-
sion and Table 2 presents the data on patients’ signs and
symptoms on admission. The most common symptoms
were hallucination and agitation. Only one patient (5%)
required intubation.
The range and mean (SD) of blood lead levels in
patients were 0.6–4.6 μg/dL and 2.3 ± 1.1 μg/dL, re-
spectively, and lead poisoning was not observed in any
of the cases. Blood lead level was not associated with
age, sex, dosage, and route of administration (Table 3).
Table 1 Vital signs of patients on admission
Range Mean (SD)
Temperature, centigrade 36–38 37 ± 0.5
Systolic blood pressure, mmHg 100–190 140 ± 24
Diastolic blood pressure, mmHg 60–140 86 ± 22
Heart rate 66–100 84 ± 11
Respiratory rate 14–26 18 ± 3
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All patients received supportive therapy. Finally, one
patient (5%) was hospitalized in ICU, 14 patients (70%)
were hospitalized in general ward, and 5 patients (25%)
were discharged.
Discussion
According to the results of this study, in the 20 patients
with sole methamphetamine poisoning, the mean (SD)
blood lead level was 2.3 ± 1.1 μg/dL, thus no case of lead
poisoning was observed in the subjects. Moreover, blood
lead level was not associated with age, sex, dosage, and
route of administration.
Despite extensive searches, we only found three studies
about lead poisoning in methamphetamine users. In
Allcott et al.’s study in 1987, lead poisoning was reported
in two patients who had been injecting illegal metham-
phetamine. According to their study, acute lead poisoning
can present with hepatitis, nephritis, and encephalopathy
[25]. In another study in 1989, lead poisoning is reported
in 12 patients who had been injecting methamphetamine.
At the same time, the tests on illegal methamphetamine
showed that up to 60% of the weight of the tested drug
was composed of lead [29]. In another study in 1996,
Norton et al. studied blood lead levels in 92 injecting
methamphetamine users and compared them with blood
lead levels in 53 substance users who were injecting other
types of substances. As the results showed, blood lead
level was 6.21 μg/dL in methamphetamine group and
7.25 μg/dL in non-methamphetamine users and there was
no significant difference between the two groups [23].
They also stated that previous reports which had sug-
gested lead poisoning in this group of patients might have
been due to accidental contamination of methampheta-
mine with lead [23].
Our study is the fourth study measuring blood lead
levels in methamphetamine users. Various combinations
of methamphetamine is used in Iran, among which crystal
(Shisheh, as common name in Iran) is the most common
form of handmade methamphetamine. Methamphetamine
is mainly used via inhalation; however, other methods
such as oral administration, smoking, and injection are
also common [31]. A large number of methamphetamine
users simultaneously use other types of opioids as well.
Hence, in our study only 20 cases of poisoning due to con-
sumption of pure methamphetamine were found within
the 6 months of the study. However, the mean blood lead
level was 2.3 μg/dL which was much lower than the levels
of poisoning. In addition, no significant relationship was
observed between blood lead level and age, sex, dosage,
and route of administration. So we can say that although
methamphetamine is illegally produced similar to other
opioids in Iran, apparently it does not have problems
related to lead poisoning which have been observed in
opioids users. Nevertheless, as the symptoms of lead
poisoning are non-specific and since many substance
users in Iran use several types of substances such as opi-
oids together with methamphetamine, lead poisoning
must be suspected in all cases of drug poisoning and, if
necessary, proper diagnostic procedures such as blood
lead levels tests must be performed to reach a definitive
diagnosis and start treatment subsequently.
Conclusion
According to the findings of this study, no case of lead
poisoning was found in the patients with sole metham-
phetamine use in our country. However, due to illegally
production of these substances, the simultaneous use of
other substances, and non-specific symptoms, lead
poisoning must be suspected in all cases of substance
poisoning and, if necessary, proper measures must be
taken to diagnose and treat the patients.
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